Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Untch

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2018
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patientsA Matikas, T Foukakis, V Moebus, et al.
Seminars in Oncology|February 1, 1997
Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancerH J Lück, C Thomssen, A du Bois, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 1997
Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nauseaS Drechsler, U Bruntsch, J Eggert, et al.
Zentralblatt Fur Gynakologie|September 17, 2002
[Evidence-based recommendations on primary treatment of carcinomas of the breast]G Von Minckwitz, K Brunnert, S D Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1B M Ryan, G E Konecny, S Kahlert, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2015
Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGM W Beckmann, I Juhasz-Böss, D Denschlag, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 30, 2008
Quality of care of VLBW neonates: relationship between unit volume and outcome is different between metropolitan and rural regionsF Jochum, B Schmidt, K Schunk, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
ABC3 Consensus Commented from the Perspective of the German Guidelines: Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015M Untch, D Augustin, J Ettl, et al.
Anticancer Research|July 31, 2012
Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancerN Ditsch, A Vodermaier, A Hinke, et al.
Anti-Cancer Drugs|August 1, 1996
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivityI A Cree, C M Kurbacher, M Untch, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2018
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patientsA Matikas, T Foukakis, V Moebus, et al.
Seminars in Oncology|February 1, 1997
Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancerH J Lück, C Thomssen, A du Bois, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 1997
Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nauseaS Drechsler, U Bruntsch, J Eggert, et al.
Zentralblatt Fur Gynakologie|September 17, 2002
[Evidence-based recommendations on primary treatment of carcinomas of the breast]G Von Minckwitz, K Brunnert, S D Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1B M Ryan, G E Konecny, S Kahlert, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2015
Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGM W Beckmann, I Juhasz-Böss, D Denschlag, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 30, 2008
Quality of care of VLBW neonates: relationship between unit volume and outcome is different between metropolitan and rural regionsF Jochum, B Schmidt, K Schunk, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
ABC3 Consensus Commented from the Perspective of the German Guidelines: Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015M Untch, D Augustin, J Ettl, et al.
Anticancer Research|July 31, 2012
Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancerN Ditsch, A Vodermaier, A Hinke, et al.
Anti-Cancer Drugs|August 1, 1996
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivityI A Cree, C M Kurbacher, M Untch, et al.
Pageof 17